메뉴 건너뛰기




Volumn 7, Issue 4, 2007, Pages 526-535

Some biochemical changes in serum and synovial fluid of patients with rheumatoid arthritis

Author keywords

Angiogenesis; Rheumatoid arthritis; Vascular endothelial growth factor (VEGF)

Indexed keywords

ALKALINE PHOSPHATASE; C REACTIVE PROTEIN; VASCULOTROPIN;

EID: 34250896117     PISSN: 16824474     EISSN: 18125727     Source Type: Journal    
DOI: 10.3923/jms.2007.526.535     Document Type: Article
Times cited : (3)

References (45)
  • 1
    • 0242319672 scopus 로고    scopus 로고
    • Adenoviral delivery of soluble VEGF receptor 1 (sFlt-1) abrogates disease activity in murine collagen-induced arthritis
    • Afuwape, A.O., M. Feldmann and E.M. Paleolog, 2003a. Adenoviral delivery of soluble VEGF receptor 1 (sFlt-1) abrogates disease activity in murine collagen-induced arthritis. Gene Ther. 10: 1950-1960.
    • (2003) Gene Ther , vol.10 , pp. 1950-1960
    • Afuwape, A.O.1    Feldmann, M.2    Paleolog, E.M.3
  • 2
    • 0036068479 scopus 로고    scopus 로고
    • The role of the angiogenic molecule VEGF in the pathogenesis of rheumatoid arthritis
    • Afuwape, A.O., S. Kiriakidis and E.M. Paleolog, 2003b. The role of the angiogenic molecule VEGF in the pathogenesis of rheumatoid arthritis. Histol. Histopathol., 17: 961-972.
    • (2003) Histol. Histopathol , vol.17 , pp. 961-972
    • Afuwape, A.O.1    Kiriakidis, S.2    Paleolog, E.M.3
  • 3
    • 0038575364 scopus 로고    scopus 로고
    • Heterogeneous requirement of IkappaB kinase 2 for inflammatory cytokine and matrix metalloproteinase production in rheumatoid arthritis: Implications for therapy
    • Andreakos, E., C. Smith, S. Kiriakidis, C. Monaco, R. de Martin, F.M. Brennan, E. Paleolog, M. Feldmann and B.M. Foxwell, 2003. Heterogeneous requirement of IkappaB kinase 2 for inflammatory cytokine and matrix metalloproteinase production in rheumatoid arthritis: Implications for therapy. Arthritis. Rheum., 48: 1901-1912.
    • (2003) Arthritis. Rheum , vol.48 , pp. 1901-1912
    • Andreakos, E.1    Smith, C.2    Kiriakidis, S.3    Monaco, C.4    de Martin, R.5    Brennan, F.M.6    Paleolog, E.7    Feldmann, M.8    Foxwell, B.M.9
  • 4
    • 0023945481 scopus 로고
    • The American Rheumatism Association 1987 revised criteria for the classification of Rheumatoid Arthritis
    • Arnett, F.C., S.M. Edworthy, D.A. Bloch et al., 1988. The American Rheumatism Association 1987 revised criteria for the classification of Rheumatoid Arthritis. Arthritis. Rheum., 31: 315-324.
    • (1988) Arthritis. Rheum , vol.31 , pp. 315-324
    • Arnett, F.C.1    Edworthy, S.M.2    Bloch, D.A.3
  • 5
    • 0035460227 scopus 로고    scopus 로고
    • Raised serum vascular endothelial growth factor levels are associated with destructive change in inflammatory arthritis
    • Ballara, S., P.C. Taylor, P. Reusch, D. Marme, M. Feldmann, R.N. Maini and E.M. Paleolog, 2001. Raised serum vascular endothelial growth factor levels are associated with destructive change in inflammatory arthritis. Arthritis Rheum., 44: 2055-64.
    • (2001) Arthritis Rheum , vol.44 , pp. 2055-2064
    • Ballara, S.1    Taylor, P.C.2    Reusch, P.3    Marme, D.4    Feldmann, M.5    Maini, R.N.6    Paleolog, E.M.7
  • 6
    • 0008362637 scopus 로고    scopus 로고
    • Hypoxia augments cytokine (transforming growth factor-beta (TGF-beta) and IL-1)-induced vascular endothelial growth factor secretion by human synovial fibroblasts
    • Berse, B., J.A. Hunt, R.J. Diegel, P. Morganelli, K. Yeo, F. Brown and R.A. Fava, 1999. Hypoxia augments cytokine (transforming growth factor-beta (TGF-beta) and IL-1)-induced vascular endothelial growth factor secretion by human synovial fibroblasts. Clin. Exp. Immunol., 115: 176-182.
    • (1999) Clin. Exp. Immunol , vol.115 , pp. 176-182
    • Berse, B.1    Hunt, J.A.2    Diegel, R.J.3    Morganelli, P.4    Yeo, K.5    Brown, F.6    Fava, R.A.7
  • 7
    • 0033956368 scopus 로고    scopus 로고
    • Placenta Growth Factor (PIGF) induces Vascular Endothelial Growth Factor (VEGF) secretion from mononuclear cells and is co-expressed with VEGF in synovial fluid
    • Bottomley, M.J., N.J. Webb, C.J. Watson, L. Holt, M. Bukhari, J. Denton, A.J. Freemont and P.E. Brenchley, 2000. Placenta Growth Factor (PIGF) induces Vascular Endothelial Growth Factor (VEGF) secretion from mononuclear cells and is co-expressed with VEGF in synovial fluid. Clin. Exp. Immunol., 119: 182-188.
    • (2000) Clin. Exp. Immunol , vol.119 , pp. 182-188
    • Bottomley, M.J.1    Webb, N.J.2    Watson, C.J.3    Holt, L.4    Bukhari, M.5    Denton, J.6    Freemont, A.J.7    Brenchley, P.E.8
  • 8
  • 9
    • 0037222724 scopus 로고    scopus 로고
    • Vascular endothelial growth factor isoforms and their receptors are expressed in human osteoarthritic cartilage
    • Enomoto, H., I. Inoki, K. Komiya, T. Shiomi, E. Ikeda, K. Obata, H. Matsumoto, Y. Toyama and Y. Okada, 2003. Vascular endothelial growth factor isoforms and their receptors are expressed in human osteoarthritic cartilage. Am. J. Pathol., 162: 171-181.
    • (2003) Am. J. Pathol , vol.162 , pp. 171-181
    • Enomoto, H.1    Inoki, I.2    Komiya, K.3    Shiomi, T.4    Ikeda, E.5    Obata, K.6    Matsumoto, H.7    Toyama, Y.8    Okada, Y.9
  • 10
    • 0028216495 scopus 로고
    • Vascular permeability factor/endothelial growth factor (VPF/VEGF): Accumulation and expression in human synovial fluids and rheumatoid synovial tissue
    • Fava, R.A., N.J. Olsen, G. Spencer-Green, K.T. Yeo, T.K. Yeo, B. Berse, R.W. Jackman, D.R. Senger, H.F. Dvorak and L.F. Brown, 1994. Vascular permeability factor/endothelial growth factor (VPF/VEGF): Accumulation and expression in human synovial fluids and rheumatoid synovial tissue. J. Exp. Med., 180: 341-346.
    • (1994) J. Exp. Med , vol.180 , pp. 341-346
    • Fava, R.A.1    Olsen, N.J.2    Spencer-Green, G.3    Yeo, K.T.4    Yeo, T.K.5    Berse, B.6    Jackman, R.W.7    Senger, D.R.8    Dvorak, H.F.9    Brown, L.F.10
  • 12
    • 10744222202 scopus 로고    scopus 로고
    • Synovial concentrations of the angiogenic peptides bFGF and VEGF do not discriminate rheumatoid arthritis from other forms of inflammatory arthritis
    • Gudbjörnsson, B., R. Christofferson and A. Larsson, 2004. Synovial concentrations of the angiogenic peptides bFGF and VEGF do not discriminate rheumatoid arthritis from other forms of inflammatory arthritis. Scand. J. Clin. Lab. Invest., 64: 9-16.
    • (2004) Scand. J. Clin. Lab. Invest , vol.64 , pp. 9-16
    • Gudbjörnsson, B.1    Christofferson, R.2    Larsson, A.3
  • 14
    • 0036822541 scopus 로고    scopus 로고
    • Hypoxia-induced production of stromal cell-derived factor 1 (CXCL12) and vascular endothelial growth factor by synovial fibroblasts
    • Hitchon, C., K. Wong, G. Ma, J. Reed, D. Lyttle and H. El-Gabalawy, 2002. Hypoxia-induced production of stromal cell-derived factor 1 (CXCL12) and vascular endothelial growth factor by synovial fibroblasts. Arthritis. Rheum., 46: 2587-2597.
    • (2002) Arthritis. Rheum , vol.46 , pp. 2587-2597
    • Hitchon, C.1    Wong, K.2    Ma, G.3    Reed, J.4    Lyttle, D.5    El-Gabalawy, H.6
  • 16
    • 0035152825 scopus 로고    scopus 로고
    • Vascular endothelial growth factor expression by activated synovial leukocytes in rheumatoid arthritis: Critical involvement of the interaction with synovial fibroblasts
    • Kasama, T., F. Shiozawa, K. Kobayashi, N. Yajima, M. Hanyuda, H.T. Takeuchi, Y. Mori, M. Negishi, H. Ide and M. Adachi, 2001. Vascular endothelial growth factor expression by activated synovial leukocytes in rheumatoid arthritis: Critical involvement of the interaction with synovial fibroblasts. Arthritis Rheum., 44: 2512-2524.
    • (2001) Arthritis Rheum , vol.44 , pp. 2512-2524
    • Kasama, T.1    Shiozawa, F.2    Kobayashi, K.3    Yajima, N.4    Hanyuda, M.5    Takeuchi, H.T.6    Mori, Y.7    Negishi, M.8    Ide, H.9    Adachi, M.10
  • 17
    • 0032435446 scopus 로고    scopus 로고
    • Serum concentrations of vascular endothelial growth factor in collagen diseases
    • Kikuchi, K., M. Kubo, T. Kadono, N. Yazawa, H. Ihn and K. Tamaki, 1998. Serum concentrations of vascular endothelial growth factor in collagen diseases. Br. J. Dermatol., 139: 1049-1051.
    • (1998) Br. J. Dermatol , vol.139 , pp. 1049-1051
    • Kikuchi, K.1    Kubo, M.2    Kadono, T.3    Yazawa, N.4    Ihn, H.5    Tamaki, K.6
  • 19
    • 0035034353 scopus 로고    scopus 로고
    • Longitudinal study of rheumatoid arthritis patients discloses sustained elevated serum levels of soluble CD106 (V-CAM)
    • Kolopp-Sarda, M.N., F. Guillemin, I. Chary-Valckenaere, M.C. Bene, J. Pourel and G.C. Faure, 2001. Longitudinal study of rheumatoid arthritis patients discloses sustained elevated serum levels of soluble CD106 (V-CAM). Clin. Exp. Rheumatol., 19: 165-170.
    • (2001) Clin. Exp. Rheumatol , vol.19 , pp. 165-170
    • Kolopp-Sarda, M.N.1    Guillemin, F.2    Chary-Valckenaere, I.3    Bene, M.C.4    Pourel, J.5    Faure, G.C.6
  • 20
    • 0035678531 scopus 로고    scopus 로고
    • Does vascular endothelial growth factor in the rheumatoid synovium predict joint destruction? A clinical, radiological and pathological study in 12 patients monitored for 10 years
    • Latour, F., L. Zabraniecki, C. Dromer, A. Brouchet, R. Durroux and B. Fournie, 2001. Does vascular endothelial growth factor in the rheumatoid synovium predict joint destruction? A clinical, radiological and pathological study in 12 patients monitored for 10 years. Joint Bone Spine, 68: 493-498.
    • (2001) Joint Bone Spine , vol.68 , pp. 493-498
    • Latour, F.1    Zabraniecki, L.2    Dromer, C.3    Brouchet, A.4    Durroux, R.5    Fournie, B.6
  • 21
    • 0034988575 scopus 로고    scopus 로고
    • Vascular endothelial growth factor levels in the serum and synovial fluid of patients with rheumatoid arthritis
    • Lee, S.S., Y.S. Joo, W.U. Kim, D.J. Min J.K. Min, S.H. Park, C.S. Cho and H.Y. Kim, 2001. Vascular endothelial growth factor levels in the serum and synovial fluid of patients with rheumatoid arthritis. Clin. Exp. Rheumatol., 19: 321-324.
    • (2001) Clin. Exp. Rheumatol , vol.19 , pp. 321-324
    • Lee, S.S.1    Joo, Y.S.2    Kim, W.U.3    Min, D.J.4    Min, J.K.5    Park, S.H.6    Cho, C.S.7    Kim, H.Y.8
  • 23
    • 0019379478 scopus 로고
    • The assessment of disease activity in rheumatoid arthritis using multivariant analysis
    • Mallaya, R.K. and B.E.W. Mace, 1981. The assessment of disease activity in rheumatoid arthritis using multivariant analysis. Rheumatology and Rehabilitation, 20: 14-17.
    • (1981) Rheumatology and Rehabilitation , vol.20 , pp. 14-17
    • Mallaya, R.K.1    Mace, B.E.W.2
  • 24
    • 0033888921 scopus 로고    scopus 로고
    • Treatment with soluble VEGF receptor reduces disease severity in murine collagen-induced arthritis
    • Miotla, J., R. Maciewicz, J. Kendrew, M. Feldmann and E. Paleolog, 2000. Treatment with soluble VEGF receptor reduces disease severity in murine collagen-induced arthritis. Lab Invest., 80: 1195-205.
    • (2000) Lab Invest , vol.80 , pp. 1195-1205
    • Miotla, J.1    Maciewicz, R.2    Kendrew, J.3    Feldmann, M.4    Paleolog, E.5
  • 25
    • 0033786484 scopus 로고    scopus 로고
    • Imbalance in production between vascular endothelial growth factor and endostatin in patients with rheumatoid arthritis
    • Nagashima, M., G. Asano and S. Yoshino, 2000a. Imbalance in production between vascular endothelial growth factor and endostatin in patients with rheumatoid arthritis. J. Rheumatol., 27: 2339-2342.
    • (2000) J. Rheumatol , vol.27 , pp. 2339-2342
    • Nagashima, M.1    Asano, G.2    Yoshino, S.3
  • 26
    • 0038798085 scopus 로고    scopus 로고
    • Anti-interleukin-6 receptor antibody therapy reduces vascular endothelial growth factor production in rheumatoid arthritis
    • Nakahara, H., J. Song, M. Sugimoto, K. Hagihara, T. Kishimoto, K. Yoshizaki and N. Nishimoto, 2003. Anti-interleukin-6 receptor antibody therapy reduces vascular endothelial growth factor production in rheumatoid arthritis. Arthritis Rheum., 48: 1521-1529.
    • (2003) Arthritis Rheum , vol.48 , pp. 1521-1529
    • Nakahara, H.1    Song, J.2    Sugimoto, M.3    Hagihara, K.4    Kishimoto, T.5    Yoshizaki, K.6    Nishimoto, N.7
  • 27
    • 0036137724 scopus 로고    scopus 로고
    • Vascular endothelial growth factors C and D and their VEGFR-2 and 3 receptors in blood and lymphatic vessels in healthy and arthritic synovium
    • Paavonen, K., J. Mandelin, T. Partanen, L. Jussila, T.F. Li, A. Ristimaki, K. Alitalo and Y.T. Konttinen, 2002. Vascular endothelial growth factors C and D and their VEGFR-2 and 3 receptors in blood and lymphatic vessels in healthy and arthritic synovium. J. Rheumatol., 29: 39-45.
    • (2002) J. Rheumatol , vol.29 , pp. 39-45
    • Paavonen, K.1    Mandelin, J.2    Partanen, T.3    Jussila, L.4    Li, T.F.5    Ristimaki, A.6    Alitalo, K.7    Konttinen, Y.T.8
  • 28
    • 0030266845 scopus 로고    scopus 로고
    • Angiogenesis: A Critical Process in the Pathogenesis of RA-A Role For VEGF?
    • Paleolog, E.M., 1996. Angiogenesis: A Critical Process in the Pathogenesis of RA-A Role For VEGF?. Br. J. Rheumatol., 35: 917-920.
    • (1996) Br. J. Rheumatol , vol.35 , pp. 917-920
    • Paleolog, E.M.1
  • 29
    • 0031725440 scopus 로고    scopus 로고
    • Angiogenesis in rheumatoid arthritis: Implications for future therapeutic strategies
    • Paleolog, E.M. and R.A. Fava, 1998. Angiogenesis in rheumatoid arthritis: Implications for future therapeutic strategies. Springer Semin. Immunopathol., 20: 73-94.
    • (1998) Springer Semin. Immunopathol , vol.20 , pp. 73-94
    • Paleolog, E.M.1    Fava, R.A.2
  • 32
    • 0036692256 scopus 로고    scopus 로고
    • Angiogenesis in health and disease: Insights into basic mechanisms and therapeutic opportunities
    • Polverini, P.J., 2002. Angiogenesis in health and disease: insights into basic mechanisms and therapeutic opportunities. J. Dent. Educ., 66: 962-975.
    • (2002) J. Dent. Educ , vol.66 , pp. 962-975
    • Polverini, P.J.1
  • 33
    • 0034946863 scopus 로고    scopus 로고
    • Splice variants VEGF121 and VEGF165 of the angiogenic peptide vascular endothelial cell growth factor are expressed in the synovial tissue of patients with rheumatoid arthritis
    • Pufe, T., W. Petersen, B. Tillmann and R. Mentlein, 2001. Splice variants VEGF121 and VEGF165 of the angiogenic peptide vascular endothelial cell growth factor are expressed in the synovial tissue of patients with rheumatoid arthritis. J. Rheumatol., 28: 1482-1485.
    • (2001) J. Rheumatol , vol.28 , pp. 1482-1485
    • Pufe, T.1    Petersen, W.2    Tillmann, B.3    Mentlein, R.4
  • 34
    • 0014305869 scopus 로고
    • Clinical studies with an articular index for the assessment of joint tenderness in patients with rheumatoid arthritis
    • Ritchie, D.M., J.E. Boyle, J.M. Mc Innes, M.K. Jasani, T.G. Dalakos, P. Grieveson and W.W. Buchanan, 1968. Clinical studies with an articular index for the assessment of joint tenderness in patients with rheumatoid arthritis. Q. J. Med., 147: 393-406.
    • (1968) Q. J. Med , vol.147 , pp. 393-406
    • Ritchie, D.M.1    Boyle, J.E.2    Mc Innes, J.M.3    Jasani, M.K.4    Dalakos, T.G.5    Grieveson, P.6    Buchanan, W.W.7
  • 35
    • 0032515980 scopus 로고    scopus 로고
    • An antagonistic Vascular Endothelial Growth Factor (VEGF) variant inhibits VEGF-stimulated receptor autophosphorylation and proliferation of human endothelial cells
    • Siemeister, G., M. Schirner, P. Reusch, B. Barleon, D. Marme and G. Martiny-Baron, 1998. An antagonistic Vascular Endothelial Growth Factor (VEGF) variant inhibits VEGF-stimulated receptor autophosphorylation and proliferation of human endothelial cells. Proc. Natl. Acad. Sci. USA., 95: 4625-4629.
    • (1998) Proc. Natl. Acad. Sci. USA , vol.95 , pp. 4625-4629
    • Siemeister, G.1    Schirner, M.2    Reusch, P.3    Barleon, B.4    Marme, D.5    Martiny-Baron, G.6
  • 37
    • 34250868143 scopus 로고    scopus 로고
    • Anti-TNF-α antibody Infliximab and glucocorticoids reduce serum Vascular Endothelial Growth Factor (VEGF) levels in patients with rheumatoid arthritis: A pilot study
    • Strunk, J., E. Heinemann and U. Lange, 2004a. Anti-TNF-α antibody Infliximab and glucocorticoids reduce serum Vascular Endothelial Growth Factor (VEGF) levels in patients with rheumatoid arthritis: A pilot study. Arthritis Res. Ther., 6(Suppl 1): 94.
    • (2004) Arthritis Res. Ther , vol.6 , Issue.SUPPL. 1 , pp. 94
    • Strunk, J.1    Heinemann, E.2    Lange, U.3
  • 38
    • 34250829422 scopus 로고    scopus 로고
    • A new approach to study angiogenesis in rheumatoid arthritis by power Doppler sonography and serum vascular endothelial growth factor level measurement
    • Strunk, J., E. Heinemann and U. Lange, 2004b. A new approach to study angiogenesis in rheumatoid arthritis by power Doppler sonography and serum vascular endothelial growth factor level measurement. Arthritis Res. Ther., 6(Suppl 1): 103.
    • (2004) Arthritis Res. Ther , vol.6 , Issue.SUPPL. 1 , pp. 103
    • Strunk, J.1    Heinemann, E.2    Lange, U.3
  • 39
    • 34247627779 scopus 로고    scopus 로고
    • VEGF and imaging of vessels in rheumatoid arthritis. Supplement Review
    • Taylor, P.C., 2002. VEGF and imaging of vessels in rheumatoid arthritis. Supplement Review. Arthritis Res., 4 (suppl 3): S99-S107
    • (2002) Arthritis Res , vol.4 , Issue.SUPPL. 3
    • Taylor, P.C.1
  • 40
    • 0034044350 scopus 로고    scopus 로고
    • Pharmacoeconomics of drug therapy for rheumatoid arthritis
    • Jun
    • Tugwell, P., 2000. Pharmacoeconomics of drug therapy for rheumatoid arthritis. Rheumatology (Oxford) Jun., 39 Suppl 1: 43-47.
    • (2000) Rheumatology (Oxford) , vol.39 , Issue.SUPPL. 1 , pp. 43-47
    • Tugwell, P.1
  • 41
    • 0037309232 scopus 로고    scopus 로고
    • Cytokine production in the infrapatellar fat pad: Another source of cytokines in knee synovial fluids
    • Ushiyama, T., T. Chano, K. Inoue and Y. Matsusue, 2003. Cytokine production in the infrapatellar fat pad: another source of cytokines in knee synovial fluids. Ann. Rheum. Dis., 62: 108-112.
    • (2003) Ann. Rheum. Dis , vol.62 , pp. 108-112
    • Ushiyama, T.1    Chano, T.2    Inoue, K.3    Matsusue, Y.4
  • 42
    • 0031913045 scopus 로고    scopus 로고
    • Focally regulated endothelial proliferation and cell death in human synovium
    • Walsh, D.A., M. Wade, P.I. Mapp and D.R. Blake, 1998. Focally regulated endothelial proliferation and cell death in human synovium. Am. J. Pathol., 152: 691-702.
    • (1998) Am. J. Pathol , vol.152 , pp. 691-702
    • Walsh, D.A.1    Wade, M.2    Mapp, P.I.3    Blake, D.R.4
  • 43
    • 0036139621 scopus 로고    scopus 로고
    • Expression and localization of vascular endothelial growth factor-C in rheumatoid arthritis synovial tissue
    • Wauke, K., M. Nagashima, T. Ishiwata, G. Asano and S. Yoshino, 2002. Expression and localization of vascular endothelial growth factor-C in rheumatoid arthritis synovial tissue. J. Rheumatol., 29: 34-38.
    • (2002) J. Rheumatol , vol.29 , pp. 34-38
    • Wauke, K.1    Nagashima, M.2    Ishiwata, T.3    Asano, G.4    Yoshino, S.5
  • 44
    • 0031797701 scopus 로고    scopus 로고
    • Localization of vascular endothelial growth factor in synovial membrane mast cells: Examination with multi-labelling subtraction immunostaining
    • Yamada, T., M. Sawatsubashi, H. Yakushiji, Y. Itoh, G. Edakuni, M. Mori, L. Robert and K. Miyazaki, 1998. Localization of vascular endothelial growth factor in synovial membrane mast cells: Examination with "multi-labelling subtraction immunostaining. Virchows Arch., 433: 567-570.
    • (1998) Virchows Arch , vol.433 , pp. 567-570
    • Yamada, T.1    Sawatsubashi, M.2    Yakushiji, H.3    Itoh, Y.4    Edakuni, G.5    Mori, M.6    Robert, L.7    Miyazaki, K.8


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.